Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 5.
A
Arfeen, Zakia;
Young, Tim;
Rashid, Mohammed Ahmed;
(2023)
Editing the editors: Aims and priorities of health professions education journals.
Medical Teacher
, 45
(2)
pp. 152-156.
10.1080/0142159X.2022.2104700.
|
C
|
Carr, Edward J;
Wu, Mary Y;
Gahir, Joshua;
Harvey, Ruth;
Townsley, Hermaleigh;
Bailey, Chris;
Fowler, Ashley S;
... Crick COVID Serology Consortium, Consortium; + view all
(2023)
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.
The Lancet Infectious Diseases
10.1016/S1473-3099(23)00289-X.
(In press).
|
 |
L
|
Liu, X;
Munro, APS;
Wright, A;
Feng, S;
Janani, L;
Aley, PK;
Babbage, G;
... Faust, SN; + view all
(2023)
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Journal of Infection
, 87
(1)
pp. 18-26.
10.1016/j.jinf.2023.04.012.
|
 |
P
|
Payne, Thomas;
Appleby, Matthew;
Buckley, Ellen;
van Gelder, Linda MA;
Mullish, Benjamin H;
Sassani, Matilde;
Dunning, Mark J;
... Bandmann, Oliver; + view all
(2023)
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Movement Disorders
10.1002/mds.29450.
(In press).
|
|
S
|
Shaw, Robert H;
Greenland, Melanie;
Stuart, Arabella Sv;
Aley, Parvinder K;
Andrews, Nick J;
Cameron, J Claire;
Charlton, Sue;
... Com-COV2 Study Group; + view all
(2023)
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal of Infection
10.1016/j.jinf.2023.03.027.
(In press).
|
